Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision

   Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO
                            Surgical, and Envision

PR Newswire

NEW YORK, December 11, 2013

NEW YORK, December 11, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting AbbVie
Inc. (NYSE: ABBV), Covance Inc. (NYSE: CVD), MannKind Corp. (NASDAQ: MNKD),
MAKO Surgical Corp. (NASDAQ: MAKO), and Envision Healthcare Holdings, Inc.
(NYSE: EVHC). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

AbbVie Inc. Research Report

On December 6, 2013, AbbVie Inc.'s (AbbVie) stock increased 3.20%, ending the
day's session at $51.35. Over the previous three trading sessions, shares of
AbbVie increased 2.76%, compared to the Dow Jones Industrial Average Index
which increased 0.66% during the same period. The Full Research Report on
AbbVie Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/273c_ABBV

Covance Inc. Research Report

On December 6, 2013, Covance Inc.'s (Covance) stock increased 2.01%, ending
the day's session at $86.82. Over the previous three trading sessions, shares
of Covance increased 3.95%, compared to the Dow Jones Industrial Average Index
which increased 0.66% during the same period. The Full Research Report on
Covance Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/5691_CVD

MannKind Corp. Research Report

On December 6, 2013, MannKind Corp.'s (MannKind) stock increased 3.02%, ending
the day's session at $5.12. Over the previous three trading sessions, shares
of MannKind increased 2.20%, compared to the Dow Jones Industrial Average
Index which increased 0.66% during the same period. The Full Research Report
on MannKind Corp. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/044e_MNKD

MAKO Surgical Corp. Research Report

On December 6, 2013, MAKO Surgical Corp.'s (MAKO Surgical) stock ended the
day's session flat at $29.97. Over the previous three trading sessions, shares
of MAKO Surgical increased 0.10%, compared to the Nasdaq Composite Index which
increased 0.63% during the same period. The Full Research Report on MAKO
Surgical Corp. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/7465_MAKO

Envision Healthcare Holdings, Inc. Research Report

On December 6, 2013, Envision Healthcare Holdings, Inc.'s (Envision) stock
increased 2.21%, ending the day's session at $30.99. Over the previous three
trading sessions, shares of Envision increased 5.88%, compared to the Dow
Jones Industrial Average Index which increased 0.66% during the same period.
The Full Research Report on Envision Healthcare Holdings, Inc. - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/4b31_EVHC

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to making mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.AnalystsCorner.com/

SOURCE Analysts' Corner

Contact: CONTACT PERSON: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North
America)
 
Press spacebar to pause and continue. Press esc to stop.